BPG is committed to discovery and dissemination of knowledge
Prospective Study
Copyright: ©Author(s) 2026.
World J Hepatol. Sep 27, 2026; 18(9): 124338
Published online Sep 27, 2026. doi: 10.4254/wjh.124338
Table 1 Baseline parameters of patients with compensated advanced chronic liver disease of different etiology, n (%)/mean ± SD
Parameters
Overall (n = 231)
MASLD (n = 52)
ArLD (n = 43)
HCV (n = 75)
HBV (n = 60)
Age (years)45.18 ± 9.7347 ± 10.739.09 ± 7.1747 ± 8.8844 ± 9.33
Male:female96:13522:3142:114: 6118:42
Hemoglobin11.66 ± 1.8711.53 ± 1.7511.82 ± 1.7611.92 ± 1.9511.37 ± 1.94
Total leukocyte count5077.0 ± 16224857 ± 14365154 ± 14545322 ±18374905 ± 1582
Platelet1.1 ± 0.431.49 ± 0.491.14 ± 0.471.43 ± 0.491.08 ±0.41
Total bilirubin1.01 ± 0.541.6 ± 0.560.92 ± 0.671.0 ± 0.461.11 ± 0.55
Conjugated bilirubin0.61 ± 0.330.7 ± 0.310.50 ± 0.330.62 ± 0.210.64 ± .13
AST64 ± 3063 ± 2371 ± 3770 ± 3354.20 ± 21
ALT49.18 ± 2648 ± 2056 ± 3752 ± 29.540.8 ± 16
ALP117 ± 43121 ± 56127 ± 36121.6 ± 38127 ± 34
Albumin4.10 ± 2.63.87 ± 0.413.84 ± 0.503.82 ± 1.384.4 ± 2.76
Protein8.8 ± 5.38.7 ± 3.18.45 ± 2.477.74 ± 0.618.1 ± 3.23
INR1.12 ± 0.191.14 ± 0.201.09 ± 0.211.11 ± 0.161.15 ± 0.20
Urea28.8 ± 9.2731 ± 10.324.5 ± 8.7528.42 ± 7.9629.8 ± 9.21
Creatinine0.88 ± 0.190.89 ± 0.190.50 ± 0.330.86 ± 0.190.89 ± 0.18
LSM23.5 ± 7.923 ± 7.321.9 ± 8.1724.5 ± 8.0623.7 ± 8.12
SSM46.4 ± 16.847.26 ± 16.4747.26 ± 17.945.6 ± 15.949.9 ± 17.42
FIB-44.45 ± 2.54.78 ± 2.633.88 ± 2.344.90 ± 2.804.03 ± 2.11
APRI1.73 ± 1.141.76 ± 1.021.89 ± 1.291.49 ± 0.941.83 ± 1.26
Decompensation19 (8.22)7 (13.4)5 (11.62)4 (5.3)3 (5)
Death5 (2.17)2 (3.8)2 (4.6)01 (1.6)


Write to the Help Desk